Antinociceptive effects of rotigotine-loaded microspheres and its synergistic interactions with analgesics in inflammatory pain in rats
Copyright © 2020. Published by Elsevier B.V..
Rotigotine-loaded microspheres (RoMS) are sustained-release formulations with prolonged anti-Parkinson's effects. Given that pain is a non-motor symptom of Parkinson's disease, this study investigated the antinociceptive effects of RoMS and their synergistic effects with analgesics on inflammatory pain. A model of inflammatory pain was prepared by intraplantarly injecting male Sprague-Dawley rats with carrageenan. The antinociceptive effects of RoMS, acetaminophen, and tramadol, both alone and in combination, were evaluated using the hind paw withdrawal latency in the hot plate test and Randall-Selitto test. The rotigotine concentrations in serum and tissues were assayed using ultra-performance liquid chromatography-tandem mass spectrometry. Isobolographic analysis was performed to evaluate the nature of the interactions of RoMS with acetaminophen or tramadol. The results showed that hind paw withdrawal latency to thermal and mechanical stimuli was significantly increased on day 3 and 7 after administered RoMS. Rotigotine could be detected in serum and tissues 3 and 7 days after an intramuscular injection of RoMS. However, the rotigotine concentration fell the detection limit of the assay on day 14 after administration. RoMS produced synergistic antinociceptive effects in the inflammatory pain model when RoMS is combined with acetaminophen or tramadol. These findings suggest that RoMS can relieve inflammatory pain in rats. Furthermore, the combination of RoMS with acetaminophen or tramadol produces synergistic antinociception, which may be clinically worthy because combination therapies may reduce the drug doses required for antinociception.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:891 |
---|---|
Enthalten in: |
European journal of pharmacology - 891(2021) vom: 15. Jan., Seite 173693 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Ting [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 20.05.2021 Date Revised 26.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.ejphar.2020.173693 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM317287192 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM317287192 | ||
003 | DE-627 | ||
005 | 20240229152335.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.ejphar.2020.173693 |2 doi | |
028 | 5 | 2 | |a pubmed24n1306.xml |
035 | |a (DE-627)NLM317287192 | ||
035 | |a (NLM)33160937 | ||
035 | |a (PII)S0014-2999(20)30785-8 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Ting |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antinociceptive effects of rotigotine-loaded microspheres and its synergistic interactions with analgesics in inflammatory pain in rats |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.05.2021 | ||
500 | |a Date Revised 26.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020. Published by Elsevier B.V. | ||
520 | |a Rotigotine-loaded microspheres (RoMS) are sustained-release formulations with prolonged anti-Parkinson's effects. Given that pain is a non-motor symptom of Parkinson's disease, this study investigated the antinociceptive effects of RoMS and their synergistic effects with analgesics on inflammatory pain. A model of inflammatory pain was prepared by intraplantarly injecting male Sprague-Dawley rats with carrageenan. The antinociceptive effects of RoMS, acetaminophen, and tramadol, both alone and in combination, were evaluated using the hind paw withdrawal latency in the hot plate test and Randall-Selitto test. The rotigotine concentrations in serum and tissues were assayed using ultra-performance liquid chromatography-tandem mass spectrometry. Isobolographic analysis was performed to evaluate the nature of the interactions of RoMS with acetaminophen or tramadol. The results showed that hind paw withdrawal latency to thermal and mechanical stimuli was significantly increased on day 3 and 7 after administered RoMS. Rotigotine could be detected in serum and tissues 3 and 7 days after an intramuscular injection of RoMS. However, the rotigotine concentration fell the detection limit of the assay on day 14 after administration. RoMS produced synergistic antinociceptive effects in the inflammatory pain model when RoMS is combined with acetaminophen or tramadol. These findings suggest that RoMS can relieve inflammatory pain in rats. Furthermore, the combination of RoMS with acetaminophen or tramadol produces synergistic antinociception, which may be clinically worthy because combination therapies may reduce the drug doses required for antinociception | ||
650 | 4 | |a Comparative Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a Antinociception | |
650 | 4 | |a Dopamine | |
650 | 4 | |a Pain | |
650 | 4 | |a Rotigotine-loaded microspheres | |
650 | 7 | |a Analgesics |2 NLM | |
650 | 7 | |a Delayed-Action Preparations |2 NLM | |
650 | 7 | |a Tetrahydronaphthalenes |2 NLM | |
650 | 7 | |a Thiophenes |2 NLM | |
650 | 7 | |a Acetaminophen |2 NLM | |
650 | 7 | |a 362O9ITL9D |2 NLM | |
650 | 7 | |a Tramadol |2 NLM | |
650 | 7 | |a 39J1LGJ30J |2 NLM | |
650 | 7 | |a rotigotine |2 NLM | |
650 | 7 | |a 87T4T8BO2E |2 NLM | |
650 | 7 | |a Carrageenan |2 NLM | |
650 | 7 | |a 9000-07-1 |2 NLM | |
700 | 1 | |a Wang, Tian |e verfasserin |4 aut | |
700 | 1 | |a Wang, Linlin |e verfasserin |4 aut | |
700 | 1 | |a Liu, Rongxia |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Leiming |e verfasserin |4 aut | |
700 | 1 | |a Zhai, Rong |e verfasserin |4 aut | |
700 | 1 | |a Fu, Fenghua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t European journal of pharmacology |d 1967 |g 891(2021) vom: 15. Jan., Seite 173693 |w (DE-627)NLM000029769 |x 1879-0712 |7 nnns |
773 | 1 | 8 | |g volume:891 |g year:2021 |g day:15 |g month:01 |g pages:173693 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ejphar.2020.173693 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 891 |j 2021 |b 15 |c 01 |h 173693 |